Search

Your search keyword '"Putluri, Vasanta"' showing total 328 results

Search Constraints

Start Over You searched for: Author "Putluri, Vasanta" Remove constraint Author: "Putluri, Vasanta"
328 results on '"Putluri, Vasanta"'

Search Results

1. Metabolomic profiles in Jamaican children with and without autism spectrum disorder

2. Vitamin B2 enables regulation of fasting glucose availability.

4. Evolution of cisplatin resistance through coordinated metabolic reprogramming of the cellular reductive state

5. Epigenome environment interactions accelerate epigenomic aging and unlock metabolically restricted epigenetic reprogramming in adulthood

9. Mitochondrial pyruvate import is a metabolic vulnerability in androgen receptor-driven prostate cancer.

10. Retraction: Tobacco-specific Carcinogens Induce Hypermethylation, DNA Adducts, and DNA Damage in Bladder Cancer

11. Loss of Nardilysin, a Mitochondrial Co-chaperone for α-Ketoglutarate Dehydrogenase, Promotes mTORC1 Activation and Neurodegeneration

12. Thioredoxin reductase is a major regulator of metabolism in leukemia cells

13. Supplementary Material and Methods from Metabolomic Rewiring Promotes Endocrine Therapy Resistance in Breast Cancer

15. Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer.

16. Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression

17. Correction: Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression

18. Metabolomic rewiring promotes endocrine therapy resistance in breast cancer

20. Distinct Lipidomic Landscapes Associated with Clinical Stages of Urothelial Cancer of the Bladder

21. Gnotobiotic Rats Reveal that Gut Microbiota Regulates Colonic mRNA of Ace2, the Receptor for SARS-CoV-2 Infectivity

22. Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression

23. Role of Adenosine Deaminase in Prostate Cancer Progression

24. Vitamin B2 enables regulation of fasting glucose availability

25. ADHFE1 is a breast cancer oncogene and induces metabolic reprogramming

26. Conjugated bile acids are nutritionally re-programmable antihypertensive metabolites

27. Data from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women

28. Supplementary Figure 3 from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women

29. Supplementary Figure Legends from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women

30. Supplementary Figure 2 from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women

31. Supplementary Table 1 from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women

32. Supplementary Figure 1 from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women

33. Supplementary Material from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women

34. Integrative Pathway Analysis of Metabolic Signature in Bladder Cancer: A Linkage to The Cancer Genome Atlas Project and Prediction of Survival

35. Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer

38. Data from Expression of Long Noncoding RNA YIYA Promotes Glycolysis in Breast Cancer

40. Supplementary Figure S5 from Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder Cancer

42. Supplement Table S5 from Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder Cancer

44. Supplementary Data from Expression of Long Noncoding RNA YIYA Promotes Glycolysis in Breast Cancer

45. Supplemental legend from Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder Cancer

47. Data from Metabolomic Profiling Reveals Potential Markers and Bioprocesses Altered in Bladder Cancer Progression

48. Supplementary Methods, Figures 1-5, Tables 1-11 from Metabolomic Profiling Reveals Potential Markers and Bioprocesses Altered in Bladder Cancer Progression

49. Vitamin B2 enables peroxisome proliferator-activated receptor α regulation of fasting glucose availability

50. Pathway-Centric Integrative Analysis Identifies RRM2 as a Prognostic Marker in Breast Cancer Associated with Poor Survival and Tamoxifen Resistance

Catalog

Books, media, physical & digital resources